Your browser doesn't support javascript.
loading
BAY 94-9027 prophylaxis is efficacious and well tolerated for up to >5 years with extended dosing intervals: PROTECT VIII extension interim results.
Lalezari, Shadan; Reding, Mark T; Pabinger, Ingrid; Holme, Pal Andre; Negrier, Claude; Chalasani, Pavani; Shin, Ho-Jin; Wang, Maria; Tseneklidou-Stoeter, Despina; Maas Enriquez, Monika.
Afiliação
  • Lalezari S; Israel National Hemophilia Center, Chaim Sheba Medical Center, Sackler School of Medicine, Tel-Aviv University, Tel Hashomer, Israel.
  • Reding MT; Center for Bleeding and Clotting Disorders, University of Minnesota Medical Center, Minneapolis, MN, USA.
  • Pabinger I; Clinical Division of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
  • Holme PA; Department of Haematology, Oslo University Hospital, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Negrier C; Hemophilia Comprehensive Care Center and Hematology Department, Louis Pradel University Hospital, Lyon, France.
  • Chalasani P; University of Arizona Cancer Center, Tucson, AZ, USA.
  • Shin HJ; Division of Hematology-Oncology, Department of Internal Medicine, Pusan National University School of Medicine, Pusan National University Hospital, Busan, Korea.
  • Wang M; Bayer, Whippany, NJ, USA.
  • Tseneklidou-Stoeter D; Bayer, Berlin, Germany.
  • Maas Enriquez M; Bayer, Wuppertal, Germany.
Haemophilia ; 25(6): 1011-1019, 2019 Nov.
Article em En | MEDLINE | ID: mdl-31621991
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Polietilenoglicóis / Segurança / Fator VIII / Hemorragia Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Child / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Polietilenoglicóis / Segurança / Fator VIII / Hemorragia Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Child / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article